Skip to main content

All Access Subscription

Get unlimited access to our full publication and article library.

Get Access Now

Interested in Group Sales? Learn more

Clinical

RSS  

Articles

  • Accounting for Patient Preference, Cardiovascular Disease Risk in Statin Therapy

    Researchers weighed patient preferences and risks regarding statin therapy after reviewing 10-year atherosclerotic cardiovascular disease risk scores.

  • Is Metformin a Wonder Drug?

    An analysis of patients taking metformin for diabetes showed they were less likely to report back, knee, neck/shoulder, or multisite musculoskeletal pain.

  • Study Reveals Increased IUD Expulsion Rate After Vaginal Delivery

    Physicians sometimes worry that women who have not given birth will have more difficulty with an intrauterine device, experiencing a higher expulsion rate. But the results of a recent study show that the opposite is true.
  • Ask Women if They Use More than One Contraceptive Method

    Nearly one out of five women used two or more methods of contraception the last time they had sexual intercourse, researchers found. Specifically, 18% of women ages 15 to 44 years who had used some form of contraception at last intercourse said they used two or more methods. Condoms and another method were the most commonly used method among dual users (58%). But women also reported using the withdrawal method, or a long-acting reversible contraceptive and another method that did not include condoms or withdrawal.
  • SAFE Intervention Brings Reproductive Health Services to Women in Treatment

    Women with opioid use disorder may avoid visiting a family planning clinic or seeing a physician for contraceptive care and counseling because of their fear of stigma and judgment. The Sex and Female Empowerment (SAFE) intervention helps this at-risk group receive evidence-based contraceptive information safely and without risk of stigma.
  • Take Practical Actions to Help Employees Cope

    Employers sometimes offer staff tips on self-care to help them cope with stress and prevent depression and other mental health issues. But there also are actions leaders can take to help prevent their staff from becoming burned out or experiencing long-term mental health problems related to the COVID-19 pandemic.
  • Watch Out for Moral Injury and Psychological Distress Among Staff

    Research into psychological distress and mental health issues during crises suggests that the world’s healthcare workers will face challenges through the pandemic and for years afterward. New data from the Centers for Disease Control and Prevention and an online survey revealed that one in 10 respondents seriously considered suicide within the past 30 days, and about one in five essential workers considered the same. Frontline professionals, and other healthcare workers to a lesser extent, are witnessing traumatic events that could lead to moral injury. Nurses and others affected by the pandemic’s trauma need education, coping tools, and therapy to help alleviate the adverse effects.
  • Reproductive Healthcare Workers Affected by Mental Health Stressors of Pandemic

    New research explores how the COVID-19 pandemic has affected the emotional and mental health of reproductive healthcare workers. Investigators surveyed reproductive health providers, including nurses, physicians, administrative staff, and others. Two-thirds of respondents reported feelings of stress, and one-third experienced increased feelings of anxiety and depression.
  • Another Agent for Hypercholesterolemia

    A pooled analysis of three randomized, controlled trials of inclisiran in patients with atherosclerotic cardiovascular disease or its risk equivalent showed impressive reductions in LDL cholesterol with subcutaneous injections every six months.

  • Importance of Atherosclerotic Disease Risk Factors in Myocardial Infarction Patients

    ST-elevation myocardial infarction patients without standard risk factors recorded a higher all-cause mortality rate that was particularly evident in women. Using proper therapy in these patients may attenuate this risk.